Summary Epidemiological evidence suggests that breastfeeding protects against breast cancer. Whether an effect of age at first breastfeeding is independent of an effect of age at first birth is unclear. We hypothesized that nausea and vomiting in pregnancy, which are associated with elevated serum oestradiol levels during pregnancy, may increase risk. Cases were 452 parous, premenopausal women, 40 years or younger, diagnosed with breast cancer in Los Angeles County from July 1983 to December 1988. Control subjects were matched to cases on age, race, parity and neighbourhood. Pregnancy and breastfeeding histories were obtained from in-person interviews. Odds of breast cancer among women who breastfed for at least 16 months relative to those among women who did not breastfeed was 0.66 [95% confidence interval (Cl) 0.41-1.05]. Number of children breastfed was not associated with risk. Risk was lower in women who first breastfed at older ages. Having ever been treated for nausea or vomiting during pregnancy was associated with an increased risk, especially in women experiencing recent pregnancies (OR = 2.03, 95% Cl 1.05-3.92). These results support a protective role of breastfeeding and an adverse role of nausea or vomiting during pregnancy in the development of premenopausal breast cancer, especially in the years immediately following pregnancy.
Although the role of breastfeeding in the development of breast cancer has been examined in many studies dating back to the early 1970s, several important issues remain unresolved. Two recent studies suggested that age at first breastfeeding modifies the protective association of duration of breastfeeding on the development of premenopausal breast cancer (Newcomb et al, 1994; Brinton et al, 1995) , but it is unclear whether the observed protective association of young age at first breastfeeding is independent of an effect of young age at first birth. Whether the protective effect of breastfeeding is modified by the number of children breastfed is also unresolved.
Previously we found that extreme nausea and vomiting of pregnancy is associated with higher levels of serum oestradiol in early pregnancy (Depue et al, 1987) . Based on this finding, we hypothesized that breast cancer risk might be elevated in women who experienced nausea and vomiting in pregnancy, supporting a role for ovarian steroid hormones in the development of breast cancer.
To clarify these issues, we examined data from a populationbased case-control study of breast cancer in young, white and Hispanic premenopausal women in Los Angeles County.
METHODS
The design of this breast cancer case-control study has been described in detail elsewhere (Bernstein et al, 1994) . Eligible subjects included all white (including Hispanic), Englishspeaking, female residents of Los Angeles County, born in the United States, Canada or Western Europe, with no history of breast cancer. Eligible case subjects were aged 40 years or younger, and were diagnosed for the first time with in situ or invasive breast cancer between 1 July 1983 and 1 January 1989. Case subjects were identified by the University of Southern California Cancer Surveillance Program, the population-based cancer registry for Los Angeles County. One neighbourhood control subject was individually matched to each case subject on birthdate (within 3 years), parity (nulliparous vs parous), and neighbourhood.
Of 969 eligible case subjects, 949 (97.9%) were alive when their physicians were asked for permission to contact them. Of 949 living eligible case subjects, 744 menarche, months of use of oral contraceptives, average number of drinks of alcohol per week at the reference date and average hours per week of physical activity during reproductive years as continuous variables, and first degree family history of breast cancer (yes, no) and race (white, Hispanic) as categorical variables. Seven per cent of the case subjects and 5% of the control subjects were Hispanic. One subject had missing data for the variable 'Ever treated for nausea or vomiting during pregnancy'; eight subjects had missing data for the variable 'Hormones given to suppress lactation' and two subjects had missing data for the variable 'Hormones given to induce or promote labour'. For each of these variables the missing subjects were assigned to the category 'Never' or 'No'. Exclusion of these matched pairs from the data set did not alter the results presented here. Because lifetime histories of physical activity were not collected from 122 case-control pairs, these subjects were arbitrarily assigned values of 0 for physical activity, which makes these matched pairs non-informative for physical activity, but allows them to contribute to the analysis of other risk factors. To test for trend in effect across categories, we used the two-sided P-value associated with the slope coefficient fit to the median value of each category of the variable.
RESULTS
On average, case subjects were slightly older than controls at first full-term pregnancy; they had fewer full-term pregnancies; and they were younger at their first menstrual period (Table 1) . Case subjects were more likely to have had a first-degree family history of breast cancer than control subjects. In addition, compared with controls, case subjects, on average, used oral contraceptives slightly longer (Table 1) , exercised less (Bernstein et al, 1994) and consumed more alcohol (not shown).
Overall, having ever breastfed a child did not confer substantial protection against the development of premenopausal breast cancer in this study (Table 2) , with 58% of cases and 60% of controls having ever breastfed a child. However, because protection may only be observed among women who breastfeed for many months or who breastfeed several children, lifetime months of breastfeeding and number of children breastfed were also evaluated. Women who breastfed for 16 months or longer were at a substantially reduced risk of developing breast cancer compared with women who never breastfed, and adjusting for other breast cancer risk factors did not markedly change this association ( Table  2 ). The number of children breastfed was not clearly associated with breast cancer risk.
We evaluated whether total duration of breastfeeding was modified by number of full-term pregnancies (Table 2 ). Longer lifetime duration of breastfeeding was clearly associated with reduced breast cancer risk among women with only one full-term pregnancy, but the association was more modest among women who had two or more full-term pregnancies. Because the small protection among women who had two or more full-term pregnancies may be due to the effect of breastfeeding after the first pregnancy, we analysed duration of breastfeeding after the first pregnancy separately from duration of breastfeeding after the second and subsequent pregnancies among women with two or more full-term pregnancies. In this group of multiparous women, duration of breastfeeding after the first pregnancy was not associated with breast cancer risk (. 8 months of breastfeeding compared with never breastfeeding: multivariate OR = 1.24, 95% CI 0.72-2.14). However, longer durations of breastfeeding following the second and subsequent pregnancies were associated with slightly reduced breast cancer risk (. 8 months breastfeeding: multivariate OR = 0.72, 95% CI 0.46-1.13).
Although the long-term effect of pregnancy is clearly to reduce breast cancer risk, there is a hypothesized dual effect of pregnancy on risk: a transient increase in risk for roughly three years following the pregnancy, followed by a long-term reduction in risk (Woods et al, 1980; Bruzzi et al, 1988; Adami et al, 1990; Williams et al, 1990; Vatten and Kvinnsland 1992; Cummings et al, 1994; Hsieh et al, 1994; Lambe et al, 1994; Albrektsen et al, 1995; Leon et al, 1995) . Because the women in this study were premenopausal and may have experienced a recent pregnancy, we analysed the breastfeeding-breast cancer association separately for women whose most recent full-term pregnancy was within 5 years of their breast cancer diagnosis (or within 5 years of the case's diagnosis for controls) and for women whose most recent full-term pregnancy was 5 years or more before the date of diagnosis (Table  2 ). Breast cancer risk was substantially reduced with longer durations of breastfeeding among women who had experienced recent full-term pregnancies, but not among women whose most recent full-term pregnancy occurred in the distant past.
We evaluated the effect of age at first breastfeeding on breast cancer risk (Table 3) . Risk appeared to decrease slightly with increasing age at first breastfeeding. We analysed lifetime duration of breastfeeding separately for women who were less than 25 years compared with older women when they breastfed for the first time ( estimates. The protective association of duration of breastfeeding with breast cancer risk was substantially greater among women who were older than among women who were younger when they first breastfed. We analysed age at first breastfeeding separately for women who breastfed their first child from women who first breastfed a later child. Among women who breastfed their first child, there was no association of age at first breastfeeding with breast cancer risk (< 20 years of age compared with never breastfeeding (multivariate OR = 1.01, 95% CI 0.55-11.83; 2 30 years of age compared with never breastfeeding, multivariate OR = 1.01, 95% CI 0.62-1.65; trend P = 0.73 (trend test restricted to women who breastfed)).
Among women who first breastfed a later child breast cancer risk decreased slightly with increasing age at first breastfeeding (< 20 years of age, multivariate OR = 1.38, 95% CI 0.20-9.69; . 30 years of age, multivariate OR = 0.82, 95% CI 0.37-1.81; trend P = 0.58).
The association of lifetime duration of breastfeeding with breast cancer risk was weakly modified by age at menarche (P for interaction = 0.10) and first-degree family history of breast cancer (P for interaction = 0.08). Lifetime duration of breastfeeding was not associated with breast cancer risk among women with menarche below age 13 years (> 16 months of breastfeeding, multivariate OR = 1.17, 95% CI 0.62-2.21). However, among women with menarche at 13 years or older, breast cancer risk was decreased substantially with increasing duration of breastfeeding (2 16 months of breastfeeding, multivariate OR = 0.33, 95% CI 0.16-0.68). Although the number of women with a first-degree family history of breast cancer who also breastfed was too small to explore the breastfeeding-breast cancer association in a multivariate analysis, a univariate analysis revealed no duration effect (2 16 months of breastfeeding compared with never breastfeeding, OR = 1.25, 95% CI 0.36-4.37). Among women with no firstdegree family history of breast cancer, the association of lifetime duration of breastfeeding with breast cancer risk was similar to the results for all women combined (2 16 months of breastfeeding, multivariate OR = 0.62, 95% CI 0.38-1.02). No evidence of effect modification by physical activity or years of oral contraceptive use on breast cancer risk was observed.
In a multivariate analysis, we found that women who had been treated for nausea or vomiting of pregnancy with drugs or hospitalization were at increased breast cancer risk compared with those who had not been so treated (Table 4) . These results did not vary by age at first full-term pregnancy (not shown). We analysed the association of treatment for nausea or vomiting of pregnancy with breast cancer separately for women with a full-term pregnancy within the past 5 years and for those with a more distant pregnancy (Table 4) . Among women with recent full-term pregnancy, the breast cancer risk was twofold higher for women who had been treated for nausea or vomiting of pregnancy than for women who had not been so treated. The association was greatly reduced among women who did not experience a recent full-term pregnancy. Breastfeeding did not reduce breast cancer risk of women who were treated for nausea or vomiting of pregnancy, but it substantially reduced the risk of women who were not treated for these conditions (Table 4 ). The findings were the same when the analysis was restricted to women who gave birth within 5 years of diagnosis (not shown).
Breast cancer risk was not associated with use of hormones to suppress lactation or exposure to hormones to induce or promote labour (Table 4) .
Excluding pairs that included a patient with in situ breast cancer (n = 40 matched pairs) did not substantially affect the results presented (not shown).
DISCUSSION
In this group of young, premenopausal women, longer duration of breastfeeding was associated with reduced breast cancer risk. Number of children breastfed was unassociated with risk, suggesting that the total duration of breastfeeding is most relevant to protection. These results are consistent with the results of other studies (Byers et al, 1985; Katsouyanni et al, 1986; McTieman and Thomas, 1986; Rosero-Bixby et al, 1987; Tao et al, 1988; Yuan et al, 1988; Layde et al, 1989; Wang et al, 1992; Yoo et al, 1992 ; UK National CC Study Group, 1993; Yang et al, 1993; Newcomb et al, 1994; Brinton et al, 1995; Romieu et al, 1996) which generally found modest protection from breast cancer with long duration of breastfeeding, especially among premenopausal women.
This protective effect of longer duration of breastfeeding was greater among women who had experienced one full-term pregnancy than among women who had experienced two or more fullterm pregnancies. We thought it important from a public health perspective to determine whether the small protection observed among women with two or more full-term pregnancies was actually due to the protective effect of breastfeeding during a woman's first pregnancy. Breast cancer risk was moderately reduced among women who breastfed for 8 months or more following their second or subsequent pregnancies, suggesting that the protective effect of increased duration of breastfeeding is not restricted to the first pregnancy.
Breast stem cells differentiate during the first full-term pregnancy and first lactation rendering them less susceptible to carcinogenesis (Russo et al, 1982) . However, unlike the findings of two recent studies (Newcomb et al, 1994; Brinton et al, 1995) age at first breastfeeding did not substantially modify the breast cancer-breastfeeding relationship. In fact, contrary to these studies, the protective association of duration of breastfeeding with breast cancer risk was greater among women who breastfed for the first time at older ages than among women who breastfed for the first time at younger ages. However, we have discussed the difficulty in determining whether any observed association of age at first breastfeeding is independent of an effect of age at first birth (Ross and Yu, 1994) . We attempted to address this issue by evaluating risk by age at first breastfeeding for women who breastfed their first child separately compared with women who only breastfed a later child. Among women who breastfed their first child, age at first breastfeeding had no effect on breast cancer risk. The small, but statistically significant, decrease in risk with increasing age at first breastfeeding among women who breastfed only children born after their first child may indicate some independent effect on breast cancer risk from that associated with age at first birth.
The breastfeeding-breast cancer association varied somewhat by age at menarche and first-degree family history of breast cancer. The protective effect of longer durations of breastfeeding was only observed among women who had experienced an older age at menarche and who had no first-degree family history of breast cancer. These findings suggest that breastfeeding may be most protective among women who do not have these well established breast cancer risk factors.
The most likely mechanism for its effect on breast cancer risk is that breastfeeding delays the resumption of ovulation postpartum (Vorherr, 1973; Gray et al, 1990) , reducing a woman's cumulative number of ovulatory cycles, thereby potentially reducing her risk of breast cancer (Henderson et al, 1985) . The return of regular ovulatory cycles tends to occur more quickly when the number of breastfeedings per day is reduced through the use of supplemental feedings (Stern et al, 1986 ). As we did not obtain information about such supplemental feedings, we are unable to evaluate its impact on our results.
Women who experienced nausea and vomiting in pregnancy requiring treatment of their symptoms had an increased breast cancer risk. We previously reported that women with intractable nausea and vomiting of pregnancy (hyperemesis gravidarum) had, on average, 26% higher first-trimester serum oestradiol levels than women who did not vomit during pregnancy, and we hypothesized that the higher oestrogen exposure may contribute to an increased breast cancer risk (Depue et al, 1987) . When we restricted the present analysis to women whose most recent pregnancy was within 5 years of diagnosis, risk was more than twofold higher among women who had been treated for nausea or vomiting of pregnancy. We did not obtain information about specific treatment regimens from the subjects, so we do not know if the observed association was limited to women receiving specific antiemetic drugs. However, the observed association probably underestimates the true risk, because we obtained information only about the most severe cases of nausea and vomiting of pregnancy; the comparison group undoubtedly included women who experienced some level of nausea or vomiting during their pregnancies but did not seek treatment. The association of breast cancer risk with treatment for nausea or vomiting of pregnancy was considerably weakened among women whose most recent pregnancy was 5 years or more before diagnosis. Breastfeeding was only associated with reduced breast cancer risk among women who were not treated for nausea and vomiting of pregnancy, regardless of the recency of the woman's last pregnancy. These findings strongly suggest that the increase in breast cancer risk associated with severe nausea and vomiting of pregnancy is transient. This in turn may be due to hormonally induced differentiation and proliferation of breast stem cells, some of which may have undergone malignant transformation (Miller, 1993) . Breastfeeding appears to protect against breast cancer in the years immediately following pregnancy, perhaps by reducing the cyclic hormonal stimulation of breast cells, except among women who have experienced severe nausea and vomiting of pregnancy. The excessively elevated oestradiol levels of such women may irreversibly promote premalignant breast cells but, further research is needed to confirm this hypothesis.
The use of hormones to suppress lactation was not associated with risk of breast cancer, similar to the findings of others (Newcomb et al, 1994) . Risk was also not associated with the use of hormones to induce or promote labour.
In this group of premenopausal women, many of whom were still bearing children or who had experienced pregnancies in the recent past, the protective role of breastfeeding and the adverse role of nausea and vomiting of pregnancy on breast cancer risk were greatest in the years immediately following pregnancy. These findings are relevant to the short-term increase in breast cancer risk following pregnancy. Breastfeeding can be promoted through the education and support of new mothers and might have an appreciable impact on future breast cancer incidence.
